instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the dosage of drug 'HEPARIN SODIUM'? | Symptomatic spontaneous superior mesenteric artery dissection treated with endovascular stent repair.
Spontaneous isolated superior mesenteric artery dissection (SISMAD) is a rare condition in which patients develop an isolated dissection of the superior mesenteric artery without traumatic or iatrogenic causes. We pres... | UNK (INFUSION) | DrugDosageText | CC BY-NC | 34386188 | 20,994,077 | 2021-08 |
What was the administration route of drug 'DAPTOMYCIN'? | Urosymphyseal fistulas in women: identification and characterization of a previously undescribed phenomenon.
Urosymphyseal fistula (USF) is a very uncommon but catastrophic condition which typically occurs in the setting of previous radiation treatment for prostate cancer. As a result, USF has only been described in ma... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34386191 | 20,739,313 | 2021-08 |
What was the administration route of drug 'ERTAPENEM SODIUM'? | Urosymphyseal fistulas in women: identification and characterization of a previously undescribed phenomenon.
Urosymphyseal fistula (USF) is a very uncommon but catastrophic condition which typically occurs in the setting of previous radiation treatment for prostate cancer. As a result, USF has only been described in ma... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34386191 | 20,739,533 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | AMPHOTERICIN B, BIAPENEM, CEFTRIAXONE SODIUM\TAZOBACTAM SODIUM, LEVOFLOXACIN, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | AMPHOTERICIN B, BIAPENEM, CEFTRIAXONE SODIUM\TAZOBACTAM SODIUM, LEVOFLOXACIN, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia fungal'. | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | AMPHOTERICIN B, BIAPENEM, CEFTRIAXONE SODIUM\TAZOBACTAM SODIUM, LEVOFLOXACIN, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
What was the dosage of drug 'BIAPENEM'? | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | UNK (FOR ABOUT ONE WEEK WHENEVER NEEDED) | DrugDosageText | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
What was the dosage of drug 'CEFTRIAXONE SODIUM\TAZOBACTAM SODIUM'? | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | UNK (FOR ABOUT ONE WEEK WHENEVER NEEDED) | DrugDosageText | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
What was the dosage of drug 'LEVOFLOXACIN'? | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | UNK (FOR ABOUT ONE WEEK WHENEVER NEEDED) | DrugDosageText | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
What was the outcome of reaction 'Anaemia'? | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | Recovering | ReactionOutcome | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
What was the outcome of reaction 'Drug-induced liver injury'? | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | Recovered | ReactionOutcome | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
What was the outcome of reaction 'Pneumonia fungal'? | Pulmonary Microascus cirrosus infection in an immunocompetent patient with bronchiectasis: A case report.
Microascus species are widely distributed and rarely cause invasive infection in humans. Here we report a case of lung Microascus cirrosus infection in an immunocompetent patient with bronchiectasis. While on syste... | Recovering | ReactionOutcome | CC BY-NC-ND | 34386343 | 19,903,784 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral amyloid angiopathy'. | Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer.
Bevacizumab is an anti-angiogenic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF) that induces the proliferation and migration of vascular endothelial cells thus, p... | BEVACIZUMAB, CISPLATIN, PACLITAXEL | DrugsGivenReaction | CC BY | 34386418 | 19,729,279 | 2021 |
What was the dosage of drug 'BEVACIZUMAB'? | Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer.
Bevacizumab is an anti-angiogenic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF) that induces the proliferation and migration of vascular endothelial cells thus, p... | SIX CYCLES EVERY 3 WEEKS | DrugDosageText | CC BY | 34386418 | 19,729,279 | 2021 |
What was the dosage of drug 'CISPLATIN'? | Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer.
Bevacizumab is an anti-angiogenic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF) that induces the proliferation and migration of vascular endothelial cells thus, p... | SIX CYCLES EVERY 3 WEEKS | DrugDosageText | CC BY | 34386418 | 19,729,279 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer.
Bevacizumab is an anti-angiogenic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF) that induces the proliferation and migration of vascular endothelial cells thus, p... | SIX CYCLES EVERY 3 WEEKS | DrugDosageText | CC BY | 34386418 | 19,729,279 | 2021 |
What was the outcome of reaction 'Cerebral amyloid angiopathy'? | Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer.
Bevacizumab is an anti-angiogenic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF) that induces the proliferation and migration of vascular endothelial cells thus, p... | Recovered | ReactionOutcome | CC BY | 34386418 | 19,729,279 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Amnesia'. | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | CEFOPERAZONE\SULBACTAM, POLYMYXIN B | DrugsGivenReaction | CC BY | 34386463 | 19,749,828 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Back pain'. | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | CEFOPERAZONE\SULBACTAM, POLYMYXIN B | DrugsGivenReaction | CC BY | 34386463 | 19,749,828 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypotonia'. | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | CEFOPERAZONE\SULBACTAM, POLYMYXIN B | DrugsGivenReaction | CC BY | 34386463 | 19,749,828 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pain in extremity'. | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | CEFOPERAZONE\SULBACTAM, POLYMYXIN B | DrugsGivenReaction | CC BY | 34386463 | 19,749,828 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Papule'. | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | CEFOPERAZONE\SULBACTAM, POLYMYXIN B | DrugsGivenReaction | CC BY | 34386463 | 19,749,828 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin hyperpigmentation'. | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | CEFOPERAZONE\SULBACTAM, POLYMYXIN B | DrugsGivenReaction | CC BY | 34386463 | 19,749,828 | 2021 |
What was the administration route of drug 'POLYMYXIN B'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | Intrathecal | DrugAdministrationRoute | CC BY | 34386463 | 19,749,828 | 2021 |
What was the dosage of drug 'CEFOPERAZONE\SULBACTAM'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | 3 G EVERY 6 H | DrugDosageText | CC BY | 34386463 | 19,749,828 | 2021 |
What was the dosage of drug 'POLYMYXIN B'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | 50,000U ONCE DAILY FOR 4 DAYS,THEN 50,000U ONCE EVERY OTHER DAY | DrugDosageText | CC BY | 34386463 | 19,749,828 | 2021 |
What was the outcome of reaction 'Amnesia'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | Recovered | ReactionOutcome | CC BY | 34386463 | 19,749,828 | 2021 |
What was the outcome of reaction 'Back pain'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | Recovered | ReactionOutcome | CC BY | 34386463 | 19,749,828 | 2021 |
What was the outcome of reaction 'Hypotonia'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | Recovered | ReactionOutcome | CC BY | 34386463 | 19,749,828 | 2021 |
What was the outcome of reaction 'Pain in extremity'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | Recovered | ReactionOutcome | CC BY | 34386463 | 19,749,828 | 2021 |
What was the outcome of reaction 'Papule'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | Recovered | ReactionOutcome | CC BY | 34386463 | 19,749,828 | 2021 |
What was the outcome of reaction 'Skin hyperpigmentation'? | Successful Treatment With Intrathecal and Intravenous Polymyxin B-Based Combination Against MDR Acinetobacter baumannii Meningitis in Pediatric Patient: A Case Report.
Background: Nosocomial meningitis with multidrug-resistant (MDR) or extensively drug-resistant (XDR) Acinetobacter baumannii is a life-threatening compl... | Recovered | ReactionOutcome | CC BY | 34386463 | 19,749,828 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dehydration'. | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | BELATACEPT, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34386544 | 19,515,510 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematuria'. | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | BELATACEPT, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34386544 | 19,497,616 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | BELATACEPT, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34386544 | 19,478,097 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Weight decreased'. | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | BELATACEPT, MYCOPHENOLATE MOFETIL, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY-NC-ND | 34386544 | 19,515,510 | 2021-03 |
What was the administration route of drug 'PREDNISOLONE'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34386544 | 19,481,895 | 2021-03 |
What was the administration route of drug 'PREDNISONE'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34386544 | 19,515,510 | 2021-03 |
What was the outcome of reaction 'Acute kidney injury'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34386544 | 19,478,097 | 2021-03 |
What was the outcome of reaction 'Dehydration'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34386544 | 19,515,510 | 2021-03 |
What was the outcome of reaction 'Haematuria'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34386544 | 19,497,616 | 2021-03 |
What was the outcome of reaction 'Hepatitis'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34386544 | 19,481,895 | 2021-03 |
What was the outcome of reaction 'Nephritis'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34386544 | 19,478,097 | 2021-03 |
What was the outcome of reaction 'Renal impairment'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34386544 | 19,478,097 | 2021-03 |
What was the outcome of reaction 'Weight decreased'? | Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.
Human adenovirus (HAdV) infections can lead to high mortality in solid organ transplant (SOT) recipients, with rare reports of donor-derived infection.
Two renal transplant recipients with HAdV-11 infection who received kidneys fro... | Recovered | ReactionOutcome | CC BY-NC-ND | 34386544 | 19,515,510 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stevens-Johnson syndrome'. | Stevens-Johnson syndrome/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance database.
The association between immune checkpoint inhibitors (ICIs) and Stevens-Johnsons syndrome (SJS) /toxic epidermal necrolysis (TEN) is unclear... | ATEZOLIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34386743 | 19,503,016 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | A case report of endovascular management of delayed upper gastrointestinal bleeding after open esophagectomy for a benign esophageal stricture.
BACKGROUND
Delayed upper gastrointestinal (GI) bleeding is a rare complication of esophagectomy and can be difficult to manage.
METHODS
A 76-year-old female represented 17 da... | EPINEPHRINE | DrugsGivenReaction | CC BY-NC-ND | 34388907 | 19,996,635 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | A case report of endovascular management of delayed upper gastrointestinal bleeding after open esophagectomy for a benign esophageal stricture.
BACKGROUND
Delayed upper gastrointestinal (GI) bleeding is a rare complication of esophagectomy and can be difficult to manage.
METHODS
A 76-year-old female represented 17 da... | EPINEPHRINE | DrugsGivenReaction | CC BY-NC-ND | 34388907 | 19,996,635 | 2021-08-04 |
What was the dosage of drug 'EPINEPHRINE'? | A case report of endovascular management of delayed upper gastrointestinal bleeding after open esophagectomy for a benign esophageal stricture.
BACKGROUND
Delayed upper gastrointestinal (GI) bleeding is a rare complication of esophagectomy and can be difficult to manage.
METHODS
A 76-year-old female represented 17 da... | 14 MILLILITER, 4 ML OF 1:10,000 ADRENALIN INJECTION | DrugDosageText | CC BY-NC-ND | 34388907 | 19,996,635 | 2021-08-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | CEFTRIAXONE, LEVOFLOXACIN, LINEZOLID, MEROPENEM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TEICOPLANIN | DrugsGivenReaction | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytopenia'. | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | CEFTRIAXONE, LEVOFLOXACIN, LINEZOLID, MEROPENEM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TEICOPLANIN | DrugsGivenReaction | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | CEFTRIAXONE, LEVOFLOXACIN, LINEZOLID, MEROPENEM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TEICOPLANIN | DrugsGivenReaction | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | CEFTRIAXONE, LEVOFLOXACIN, LINEZOLID, MEROPENEM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TEICOPLANIN | DrugsGivenReaction | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | CEFTRIAXONE, LEVOFLOXACIN, LINEZOLID, MEROPENEM, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, TEICOPLANIN | DrugsGivenReaction | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
What was the outcome of reaction 'Anaemia'? | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | Recovered | ReactionOutcome | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
What was the outcome of reaction 'Cytopenia'? | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | Recovered | ReactionOutcome | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
What was the outcome of reaction 'Myelosuppression'? | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | Recovered | ReactionOutcome | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
What was the outcome of reaction 'Thrombocytopenia'? | Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
BACKGROUND
Hemophagocytic syndrome (HPS) is a severe hyperinflammatory disease, whose diagnosis is based on the HLH-2004 criteria. In secondary forms of HLH (sHLH), the primary goal is treating the triggering factors such as COVID-19 (Coronavirus... | Recovered | ReactionOutcome | CC BY | 34388982 | 20,453,558 | 2021-08-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin toxicity'. | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | ACETAMINOPHEN, ALPROSTADIL, AMINO ACIDS\DEXTROSE\ELECTROLYTES NOS, CAFFEINE CITRATE, DOPAMINE HYDROCHLORIDE, FUROSEMIDE, HYDROCORTISONE HEMISUCCINATE, INSULIN NOS, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 34388991 | 19,787,243 | 2021-08-13 |
What was the administration route of drug 'ACETAMINOPHEN'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the administration route of drug 'CAFFEINE CITRATE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the administration route of drug 'CAFFEINE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,827,938 | 2021-08-13 |
What was the administration route of drug 'DOPAMINE HYDROCHLORIDE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,787,243 | 2021-08-13 |
What was the administration route of drug 'FUROSEMIDE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the administration route of drug 'HYDROCORTISONE HEMISUCCINATE ANHYDROUS'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the administration route of drug 'HYDROCORTISONE HEMISUCCINATE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,787,243 | 2021-08-13 |
What was the administration route of drug 'HYDROCORTISONE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,827,938 | 2021-08-13 |
What was the administration route of drug 'INSULIN NOS'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,787,243 | 2021-08-13 |
What was the administration route of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the administration route of drug 'VANCOMYCIN HYDROCHLORIDE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the administration route of drug 'VANCOMYCIN'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34388991 | 19,827,938 | 2021-08-13 |
What was the dosage of drug 'CAFFEINE CITRATE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | 2.5 MG/ML | DrugDosageText | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the dosage of drug 'FUROSEMIDE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | 10 MG/ML | DrugDosageText | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the dosage of drug 'HYDROCORTISONE HEMISUCCINATE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | 2.5 MG/ML | DrugDosageText | CC BY | 34388991 | 19,787,243 | 2021-08-13 |
What was the dosage of drug 'VANCOMYCIN HYDROCHLORIDE'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | 5 MG/ML | DrugDosageText | CC BY | 34388991 | 19,786,037 | 2021-08-13 |
What was the dosage of drug 'VANCOMYCIN'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | 5 MG/ML | DrugDosageText | CC BY | 34388991 | 19,847,343 | 2021-08-13 |
What was the outcome of reaction 'Skin necrosis'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Recovered | ReactionOutcome | CC BY | 34388991 | 19,847,343 | 2021-08-13 |
What was the outcome of reaction 'Skin toxicity'? | Case report: risk of skin necrosis related to injectable vancomycin in critically ill newborn infants.
Vancomycin is commonly used as part of empiric antibiotic therapy in the preterm infants who develop signs and symptoms of infection. Although skin necrosis has been noted to occur following injection of vancomycin in... | Recovered | ReactionOutcome | CC BY | 34388991 | 19,787,243 | 2021-08-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood pressure abnormal'. | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | METHYLPREDNISOLONE | DrugsGivenReaction | CC BY | 34389019 | 19,874,994 | 2021-08-13 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the administration route of drug 'METHOTREXATE'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | Subcutaneous | DrugAdministrationRoute | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the administration route of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the administration route of drug 'PREDNISONE'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | Oral | DrugAdministrationRoute | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the dosage of drug 'ALBUMIN HUMAN'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | UNKNOWN | DrugDosageText | CC BY | 34389019 | 19,794,807 | 2021-08-13 |
What was the dosage of drug 'FUROSEMIDE'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | UNKNOWN | DrugDosageText | CC BY | 34389019 | 19,794,807 | 2021-08-13 |
What was the dosage of drug 'HUMAN IMMUNOGLOBULIN G'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | 2 G/KG | DrugDosageText | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the dosage of drug 'METHOTREXATE'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | 20 MG SUBCUTANEOUS METHOTREXATE (15 MG/M2) | DrugDosageText | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the dosage of drug 'METHYLPREDNISOLONE SODIUM SUCCINATE'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | 30 MG/KG, 1X/DAY | DrugDosageText | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | 30 MG/KG/DAY FOR 3 DAYS | DrugDosageText | CC BY | 34389019 | 19,874,994 | 2021-08-13 |
What was the dosage of drug 'PREDNISONE'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | 30 MG (0.5 MG/KG) ORAL PREDNISONE | DrugDosageText | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the dosage of drug 'RITUXIMAB'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | 1 G OF RITUXIMAB (750 MG/M2 UP TO 1 G) | DrugDosageText | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the outcome of reaction 'Blood pressure abnormal'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | Recovered | ReactionOutcome | CC BY | 34389019 | 19,874,994 | 2021-08-13 |
What was the outcome of reaction 'Hypotension'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | Recovered | ReactionOutcome | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
What was the outcome of reaction 'Pulse pressure increased'? | Anasarca as the presenting symptom of juvenile dermatomyositis: a case series.
BACKGROUND
Juvenile Dermatomyositis (JDM) is an autoimmune disease that typically presents with classic skin rashes and proximal muscle weakness. Anasarca is a rare manifestation of this disease and is associated with a more severe and refra... | Recovered | ReactionOutcome | CC BY | 34389019 | 19,828,034 | 2021-08-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Refractory catatonia in old age: a case report.
BACKGROUND
Catatonia is a clinical syndrome characterized by psychomotor disruption, which often goes undiagnosed. Most reports have focused on interventions and outcomes for catatonia in younger people and those with schizophrenia. The clinical characteristics and course... | LORAZEPAM, MIRTAZAPINE, RISPERIDONE, SERTRALINE HYDROCHLORIDE, ZOLPIDEM TARTRATE | DrugsGivenReaction | CC BY | 34389061 | 19,806,930 | 2021-08-14 |
What is the weight of the patient? | Refractory catatonia in old age: a case report.
BACKGROUND
Catatonia is a clinical syndrome characterized by psychomotor disruption, which often goes undiagnosed. Most reports have focused on interventions and outcomes for catatonia in younger people and those with schizophrenia. The clinical characteristics and course... | 70 kg. | Weight | CC BY | 34389061 | 19,781,239 | 2021-08-14 |
What was the outcome of reaction 'Pneumonia aspiration'? | Refractory catatonia in old age: a case report.
BACKGROUND
Catatonia is a clinical syndrome characterized by psychomotor disruption, which often goes undiagnosed. Most reports have focused on interventions and outcomes for catatonia in younger people and those with schizophrenia. The clinical characteristics and course... | Recovered | ReactionOutcome | CC BY | 34389061 | 19,806,930 | 2021-08-14 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
When treating indolent B-cell lymphoma, combining continuously administered oral phosphatidylinositol 3-kinase (PI3K) inhibitors with immunochemothe... | COPANLISIB, CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, PREDNISONE, RITUXIMAB, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC-ND | 34389273 | 19,793,386 | 2021-11 |
What was the administration route of drug 'COPANLISIB'? | Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
When treating indolent B-cell lymphoma, combining continuously administered oral phosphatidylinositol 3-kinase (PI3K) inhibitors with immunochemothe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34389273 | 19,793,386 | 2021-11 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma.
When treating indolent B-cell lymphoma, combining continuously administered oral phosphatidylinositol 3-kinase (PI3K) inhibitors with immunochemothe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34389273 | 19,793,386 | 2021-11 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.